PPR 2020 - 3rd Annual Pharma Pricing, Reimbursement & Market Access 2020 (Virtual Conference)

3rd Annual Pharma Pricing, Reimbursement & Market Access 2020
02nd - 03rd December 2020, Virtual Conference (Time Zone - EST)
This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
Please contact KAVITHA on E-mail - kavitha-AT-virtueinsight.co.in
FEATURES OF OUR VIRTUAL CONFERENCE:
This virtual conference is a platform to connect, engage and network with industry professionals & solution providers while saving time and ensures enhancement of knowledge at ease.
 Attend all sessions through this webinar (Solo presentations and interactive panel discussions)
 Delegates can see the other delegates and can network with them at the networking lounge at any time during the conference day.
 Delegates can see the exhibitors in their respective booths and they can visit the booths and have a private chat with the exhibitors.
CONFERENCE DELEGATE REGISTRATION:
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.
Early Bird Discount Price:
1 Delegate-AT-US$ 350 + VAT (Valid until 12th October 2020)
3 Delegates-AT-US$ 900 + VAT (Valid until 12th October 2020)
Standard Price:
1 Delegate-AT-US$ 499 + VAT (Valid from 13th October2020)
Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to kavitha-AT-virtueinsight.co.in
KEY SPEAKERS:
• ROBYN BENT, Director, CDER Patient, Focused Drug Development Program, FDA
• ROBERT POPOVIAN, Vice President, US Government Relations, Pfizer
• BEHZAD MAHDAVI, VP Strategic Innovation & Alliances, Lonza
• WENDY ERLER, VP, Patient Experience / STAR & Patient Advocacy, Alexion Pharmaceuticals
• SARA YIN, Senior Director of Access Marketing, Epizyme
• JENNIFER WONG, Senior Director, Real World Evidence, Strategy & Alliances, AstraZeneca
• MARTIN ROST, Senior Director, Market Access (Global), Pfizer
• TIMOTHY LENEHAN, Senior Director - Global Head of Pricing and Payer Access Solutions, Biogen
• MATTHEW HURLBURT, Global Access Transformation Lead, Pfizer
• RICHARD LINER, Senior Compliance Counsel, Bayer
• ALEEN HOSDAGHIAN, Sr. Director of Marketing, Sun Pharma
• TIM HERMES, VP Market Access, Trade & Patient Services, Aurinia Pharmaceuticals
• CHARLES MAKIN, Global Head, Real World Evidence Strategy, Biogen
• ALAN POLNARIEV, Medical Science Liaison, Oncology/Urology Gastroenterology, Ferring Pharmaceuticals
• GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals
• AMY PETERPAUL, Executive Director of Pricing, Contracting & Value Strategies, Helsinn
• SAM MURPHY, VP and Head of International BD, Shenzhen Salubris Pharmaceuticals
• ANKA EHRHARDT, Science Director, CHDI Foundation
• BOXIONG TANG, Sr. Director, BeiGene
• HEATHER LEIGH FLANNERY, Global Lead, ConsenSys Health
• MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalitions
• SHANTHY KRISHNARAJAH, Senior Director, Global Health Economics Reimbursement Strategy, Seqirus
• TIM EPPLE, Principal, Financial Services, Avalere Health
• SUSAN THORNTON, CEO, Cutaneous Lymphoma Foundation
• KEVIN MAYO, Managing Partner, Value Genome
• EVERETT CROSLAND, VP of Market Access & Reimbursement, AppliedVR
• MELVA COVINGTON, Senior Director, EVERSANA, Health Economics and Outcomes Research
• REED STEPHENS, Partner-In-Charge Washington, D.C. Health Industry Advisory Group, McDermott Will & Emery
• STACEY L. WORTHY, Partner, DCBA Law & Policy
• SAIRA SULTAN, President & CEO, Connect 4 Strategies
Get more from the event, with a broader scope bringing the whole communications value chain together.